Welcome to our dedicated page for Emerson Elec Co SEC filings (Ticker: EMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Emerson Electric Co. (EMR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, which offer detailed insight into its automation‑focused business and corporate governance. Emerson is incorporated in Missouri and lists its common stock on the New York Stock Exchange under the symbol EMR, as reflected in its current reports on Form 8‑K.
Through its filings, Emerson describes itself as a global automation and industrial technology company with a portfolio that includes intelligent devices, control systems, industrial software and industrial AI. Current reports on Form 8‑K outline key developments such as changes to segment reporting, where the company explains its five segments: Control Systems & Software, Test & Measurement, Sensors, Final Control and Safety & Productivity. These filings detail how segments are grouped into Software & Systems and Intelligent Devices and describe the types of technologies and brands within each segment.
Emerson’s definitive proxy statement on Schedule 14A provides information on its annual meeting, board structure, executive compensation framework and its value creation approach, including a focus on growth, margin expansion, cash generation and returning cash to shareholders. Other 8‑K filings discuss earnings press releases, share repurchase authorizations and performance‑based equity awards for senior executives, giving additional context on capital allocation and incentive design.
Debt‑related filings, such as Form 25 for a specific series of notes, document the removal of particular debt securities from exchange listing without affecting the listing of EMR common stock. On Stock Titan, these filings are updated as they appear in the SEC’s EDGAR system. AI‑powered tools can help summarize lengthy documents like proxy statements and 8‑Ks, highlight segment descriptions, compensation structures and capital return plans, and make it easier to locate information on topics such as segment definitions, governance practices and security listings within Emerson’s disclosure record.
Emerson Electric (EMR) reported insider activity for Chief Technology Officer Peter Zornio. On 11/03/2025, he acquired 10,668 common shares pursuant to a performance share award under a shareholder‑approved plan, following achievement of targets for the period ended September 30, 2025. The company withheld 4,199 shares to cover required taxes at a fair market value of $139.46 per share. He also received a grant of 1,891 restricted stock units under the plan.
Following these transactions, Zornio beneficially owned 65,580 shares directly, plus 1,934.13 shares indirectly through a 401(k) plan.
Emerson Electric (EMR) reported an insider equity transaction by Senior VP & CMO Vidya Ramnath. On 11/03/2025, the officer acquired 10,387 shares upon payout of a performance share award under a shareholder‑approved plan pursuant to Rule 16b-3, reflecting achieved financial targets for the period ended September 30, 2025.
To cover required taxes at a fair market value of $139.46, 2,494 shares were withheld. The officer also received a grant of 3,234 restricted stock units pursuant to Rule 16b-3(d). Following these transactions, 36,872 shares were beneficially owned on a direct basis.
Emerson Electric (EMR) officer Nicholas J. Piazza reported equity transactions on 11/03/2025. He acquired 6,045 shares upon payout of earned performance share units under a shareholder-approved plan pursuant to Rule 16b-3. To cover required taxes at a fair market value of $139.46, 2,664 shares were withheld. He also received a grant of 5,958 restricted stock units under Rule 16b-3(d).
Following these transactions, Piazza directly beneficially owned 40,129 shares. His role is listed as Senior VP & CPO.
Emerson Electric (EMR) reported an insider equity award. Senior Vice President, Secretary & Chief Legal Officer Michael Tang acquired 7,149 restricted stock units on 11/03/2025, coded “A” under Rule 16b-3(d) as a grant from a shareholder‑approved plan.
Following this grant, Tang beneficially owns 37,196 shares (direct). The RSU grant carries no purchase price per the filing notes.
Emerson Electric Co. furnished a press release announcing its fourth-quarter and full-year results and outlined the use of certain non-GAAP measures. The company cautioned that forward-looking statements are subject to risks described in its most recent Annual Report and subsequent SEC filings.
Separately, the Board authorized the repurchase of up to 50 million shares of common stock over the next several years. This authorization is in addition to the 60 million share program approved in March 2020, which has approximately 20 million shares remaining. Repurchases may occur in open market or private transactions at management’s discretion, may be suspended at any time, and repurchased shares may be used for employee benefit plans and other corporate purposes.
Emerson Electric (EMR) received a Form 25 filing from the New York Stock Exchange to remove its 1.250% Notes due 2025 from listing and/or registration under Section 12(b) of the Exchange Act.
The NYSE certifies compliance with its rules to strike the class from listing, and the filing notes issuer compliance with Exchange rules and 17 CFR 240.12d2-2 provisions governing voluntary withdrawal.
Emerson Electric (EMR) Q3-25 10-Q highlights:
- Net sales rose 4% YoY to $4.55 bn; underlying growth +3% (price +2.5 ppts, volume +0.5 ppt).
- Diluted EPS from continuing ops surged 72% to $1.03, aided by the absence of last year’s $0.38 Copeland note loss; adjusted EPS up 6% to $1.52.
- Segment mix: Intelligent Devices sales +4% (margin 22.5%), Software & Control +3% (margin 16.7%); Test & Measurement loss narrowed sharply ($-26 m vs $-88 m).
- YTD (9 mo) sales +2% to $13.16 bn; diluted EPS $2.91 vs $1.84. Gross margin improved 260 bp to 53.2% on lower purchase-accounting amortization and pricing.
- AspenTech consolidation: on 12 Mar 25 EMR bought remaining AspenTech shares for ~$7.2 bn; AspenTech now in Control Systems & Software. Deal drove $7.2 bn equity reduction, $1.5 bn new long-term notes and $5.4 bn commercial paper.
- Balance sheet shifts: Cash fell to $2.2 bn (-$1.4 bn YTD); short-term borrowings jumped to $6.0 bn; net debt/EBITDA pro-forma ~2.6×. Equity down to $19.9 bn from $27.5 bn as NCI largely eliminated.
- Operating cash flow modestly lower at $2.09 bn (-7% YoY); capex $263 m; financing outflow $3.0 bn (buybacks, dividends, AspenTech purchase).
- Backlog stands at $8.9 bn; 75% expected to convert within 12 months.
- Effective tax rate Q3 21% (up 200 bp) and YTD 25% (up 500 bp) due to AspenTech-related discrete items.
Key takeaways: Emerson delivered solid topline and adjusted profit growth while integrating AspenTech, but leverage, lower cash and higher taxes temper the near-term outlook.